Parker Magin1, Anousha Victoire, Xi May Zhen, John Furler, Marie Pirotta, Daniel S Lasserson, Christopher Levi, Amanda Tapley, Mieke van Driel. 1. From the Centre for Translational Neuroscience and Mental Health Research (C.L.), Discipline of General Practice, School of Medicine and Public Health (P.M., A.V.), University of Newcastle, New South Wales, Australia; Discipline of General Practice, School of Medicine, University of Queensland, Brisbane, Queensland, Australia (X.M.Z, M.v.D.); Department of General Practice, University of Melbourne, Victoria, Australia (J.F., M.P.); Department of Primary Care Health Sciences, University of Oxford, Oxford, UK (D.L.); and General Practice Training Valley to Coast, New South Wales, Australia (P.M., A.V., A.T.).
Abstract
BACKGROUND AND PURPOSE: The 2001 Revised Consolidated Standards of Reporting of Trials (CONSORT) statement requires reporting of Randomized Controlled Trials (RCTs) to include participants' baseline demographics. This enables comparison of intervention and control groups on potential confounding variables as well as assessment of study generalizability. Socioeconomic status (SES) is associated with access to care and outcomes (mortality, functional outcome, recurrent stroke, and hospital readmission) poststroke. We aimed to document the reporting of baseline SES in reports of RCTs of stroke and transient ischemic attack. METHODS: Measures of SES were extracted from studies reporting trials of stroke or transient ischemic attack published in 12 major journals in the disciplines of general medicine, general neurology, cerebrovascular disease, and rehabilitation subsequent to revised CONSORT. Percentages of studies reporting SES measures were calculated. Differences in reporting between journal categories, and temporal trends in reporting, were tested. RESULTS: Only 12% of studies reported any SES measure. Journal categories did not differ in rate of SES reporting. SES reporting did not increase over time. CONCLUSIONS: Improving reporting of SES could enhance clinicians' ability to evaluate RCT findings and apply them to their patients.
BACKGROUND AND PURPOSE: The 2001 Revised Consolidated Standards of Reporting of Trials (CONSORT) statement requires reporting of Randomized Controlled Trials (RCTs) to include participants' baseline demographics. This enables comparison of intervention and control groups on potential confounding variables as well as assessment of study generalizability. Socioeconomic status (SES) is associated with access to care and outcomes (mortality, functional outcome, recurrent stroke, and hospital readmission) poststroke. We aimed to document the reporting of baseline SES in reports of RCTs of stroke and transient ischemic attack. METHODS: Measures of SES were extracted from studies reporting trials of stroke or transient ischemic attack published in 12 major journals in the disciplines of general medicine, general neurology, cerebrovascular disease, and rehabilitation subsequent to revised CONSORT. Percentages of studies reporting SES measures were calculated. Differences in reporting between journal categories, and temporal trends in reporting, were tested. RESULTS: Only 12% of studies reported any SES measure. Journal categories did not differ in rate of SES reporting. SES reporting did not increase over time. CONCLUSIONS: Improving reporting of SES could enhance clinicians' ability to evaluate RCT findings and apply them to their patients.
Authors: Gillian D Kerr; Helen Slavin; Donna Clark; Fiona Coupar; Peter Langhorne; David J Stott Journal: Cerebrovasc Dis Date: 2010-10-28 Impact factor: 2.762
Authors: Eboni G Price-Haywood; Jewel Harden-Barrios; Christopher Carr; Laya Reddy; Lydia A Bazzano; Mieke L van Driel Journal: Qual Life Res Date: 2018-11-21 Impact factor: 4.147
Authors: Kathryn M Stadeli; Mariam N Hantouli; Elena G Brewer; Elizabeth Austin; Kemi M Doll; Danielle C Lavallee; Giana H Davidson Journal: Am J Surg Date: 2019-07-29 Impact factor: 2.565
Authors: S Wolf; S E Holm; T Ingwersen; C Bartling; G Bender; G Birke; A Meyer; A Nolte; K Ottes; O Pade; M Peller; J Steinmetz; C Gerloff; G Thomalla Journal: Ann Med Date: 2022-12 Impact factor: 4.709